Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
48.23
-1.75 (-3.50%)
At close: Mar 28, 2025, 4:00 PM
48.34
+0.11 (0.23%)
After-hours: Mar 28, 2025, 7:58 PM EDT
Pro-Dex Revenue
Pro-Dex had revenue of $16.79M in the quarter ending December 31, 2024, with 33.40% growth. This brings the company's revenue in the last twelve months to $61.00M, up 26.45% year-over-year. In the fiscal year ending June 30, 2024, Pro-Dex had annual revenue of $53.84M with 16.83% growth.
Revenue (ttm)
$61.00M
Revenue Growth
+26.45%
P/S Ratio
2.67
Revenue / Employee
$412,189
Employees
148
Market Cap
157.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 53.84M | 7.76M | 16.83% |
Jun 30, 2023 | 46.09M | 4.05M | 9.62% |
Jun 30, 2022 | 42.04M | 4.01M | 10.55% |
Jun 30, 2021 | 38.03M | 3.20M | 9.17% |
Jun 30, 2020 | 34.83M | 7.66M | 28.20% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PDEX News
- 2 months ago - Q4 2024 Portfolio Update: Growth Has Come Patiently - Seeking Alpha
- 2 months ago - Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results - Accesswire
- 5 months ago - PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results - Accesswire
- 6 months ago - Pro-Dex Inc (PDEX) Stock Price Up 3.99% on Oct 2 - GuruFocus
- 7 months ago - Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results - Accesswire
- 11 months ago - Pro-Dex, Inc. Announces Fiscal 2024 Third Quarter And Nine-Month Results - Accesswire
- 1 year ago - Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results - Accesswire
- 1 year ago - Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results - Accesswire